Viewing StudyNCT06216301



Ignite Creation Date: 2024-05-06 @ 8:00 PM
Last Modification Date: 2024-10-26 @ 3:18 PM
Study NCT ID: NCT06216301
Status: RECRUITING
Last Update Posted: 2024-01-22
First Post: 2023-12-29

Brief Title: LUNAR-2 TTFields With Pembrolizumab Platinum-based Chemotherapy for Metastatic NSCLC
Sponsor: NovoCure GmbH
Organization: NovoCure Ltd

Conditions & Keywords Data

Conditions:
Name
Metastatic Non-small Cell Lung Cancer
Keywords:
Name View
NSCLC View
Metastatic View